Amicus prices Galafold at $315k per year

By Alicia Parker | Aug 13, 2018 | 7:53 PM GMT

Amicus Therapeutics Inc. (NASDAQ:FOLD) said Monday that it will price Galafold migalastat at $315,000 per year and vowed to limit